Human Genome Sciences Stock Price and Value Analysis

Should you buy Human Genome Sciences stock? (NASDAQ:HGSI). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Human Genome Sciences to reach your target.

Target type
AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the HGSI Numbers

HGSI Price
(Human Genome Sciences stock price per share)
$14.24
[?] PE Ratio versus Sector 100% lower than other Unknown stocks
[?] PE Ratio versus Industry 100% lower than other Unknown stocks
[?] Cash Yield -14.64%
[?] Free Cash Flow Jitter 43%

Continue Learning: Value Investing Guides

Is Human Genome Sciences Stock on Sale?

Based on our analysis, we believe that you should not buy Human Genome Sciences right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy HGSI Stock?

Does Human Genome Sciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: HGSI

This example shows how we apply the Trendshare checklist to HGSI: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 14.24
    • Market cap: $2.8B
    • EPS: -1.795
  2. Step 2 — Valuation checks

    • P/E:
    • FCF yield: -14.6%
    • Date checked: Nov 25, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.